Literature DB >> 1078832

Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts.

H S Shin, M Hayden, S Langley, N Kaliss, M R Smith.   

Abstract

Syngeneic or allogeneic mice pretreated with sublethal whole-body irradiation were rendered incapable of suppressing the growth of grafted tumor cells sensitized with alloantibody. The growth of sensitized tumor cells was suppressed when they were mixed with donor effector cells from mice syngeneic or allogeneic to the recipients and then were inoculated in irradiated recipients. Three donor-host combinations were used to study the suppression of the murine lymphoma 6C3HED indigenous to C3H mice. These were C3H donor cells in C3H recipients, C57BL/6 donor cells in C3H recipients, or C57BL/6 donor cells in C57BL/6 recipients. In all three combinations, macrophages obtained from an inflammatory exudate, exudate lymphocytes not bearing theta antigen, and platelets were, in descending order of effectiveness, consistently active in restoring antibody-mediated suppression of tumor growth in irradiated hosts. Prior irradiation of the transferred lymphocytes somewhat diminished their effectiveness. Freeze-thawed or heat-killed macrophages (but not freeze-thawed platelets or lymphocytes) were effective in restoration. Peripheral blood mononuclear leukocytes and splenic lymphoid cells were not active in the recipients syngeneic to the donor cells but were acitve in recipients allogeneic to the donor cells. Polymorphonuclear leukocytes isolated from peripheral blood or an inflammatory exudate were not active. Intact thymic function seems unimportant since antibody-mediated suppression took place as effectively in thymectomized mice as in normal controls.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1078832

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Regulation of immune response to tumor antigen: interference with syngeneic tumor immunity by anti-IA alloantisera.

Authors:  L L Perry; M E Dorf; B Benacerraf; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

2.  Two mechanisms for platelet-mediated killing of tumour cells: one cyclo-oxygenase dependent and the other nitric oxide dependent.

Authors:  M Okada; T Sagawa; A Tominaga; T Kodama; Y Hitsumoto
Journal:  Immunology       Date:  1996-09       Impact factor: 7.397

3.  Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type 1 infection.

Authors:  J T Rector; R N Lausch; J E Oakes
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

4.  Macrophage migratory dysfunction in cancer. A mechanism for subversion of surveillance.

Authors:  R Snyderman; M C Pike
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

5.  Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis.

Authors:  P D Smith; K Ohura; H Masur; H C Lane; A S Fauci; S M Wahl
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

6.  Anti-inflammation induced by counter-irritation or by treatment with non-steroidal agents inhibits the growth of a tumour of non-detected immunogenicity.

Authors:  D O Sordelli; P A Fontán; R P Meiss; R A Ruggiero; O D Bustuoabad
Journal:  Br J Cancer       Date:  1989-11       Impact factor: 7.640

7.  Platelet-mediated cytotoxicity. Role of antibody and C3, and localization of the cytotoxic system in membranes.

Authors:  S Slezak; D E Symer; H S Shin
Journal:  J Exp Med       Date:  1987-08-01       Impact factor: 14.307

8.  A requirement for membrane-associated phospholipase A2 in platelet cytotoxicity activated by receptors for immunoglobulin G and complement.

Authors:  D E Symer; W A Paznekas; H S Shin
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

9.  Murine malignant cells synthesize a 19,000-dalton protein that is physicochemically and antigenically related to the immunosuppressive retroviral protein, P15E.

Authors:  G J Cianciolo; M E Lostrom; M Tam; R Snyderman
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

10.  Resistance of neoplasms to immunological destruction: role of a macrophage chemotaxis inhibitor.

Authors:  G R Pasternack; R Snyderman; M C Pike; R J Johnson; H S Shin
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.